[
    "{\"step_by_step_thinking\": \"Document [0] directly addresses the question. It states that sst2a IHC of tumor samples has no additional value compared to SRS uptake using OctreoScan\u00ae in predicting tumor response after PRRT. This suggests that there is no additional value of using Somatostatin Receptor Subtype 2a Immunohistochemistry compared to Somatostatin Receptor Scintigraphy Uptake in predicting Gastroenteropancreatic Neuroendocrine Tumor Response.\", \"answer_choice\": \"B. no\"}"
]